Biomedical Politics

Front Cover
National Academies Press, Jan 15, 1991 - Medical - 345 pages
0 Reviews
The abortifacient RU-486 was born in the laboratory, but its history has been shaped by legislators, corporate marketing executives, and protesters on both sides of the abortion debate.
This volume explores how society decides what to do when discoveries such as RU-486 raise complex and emotional policy issues. Six case studies with insightful commentary offer a revealing look at the interplay of scientists, interest groups, the U.S. Congress, federal agencies, and the public in determining biomedical public policy--and suggest how decision making might become more reasoned and productive in the future.
The studies are fascinating and highly readable accounts of the personal interactions behind the headlines. They cover dideoxyinosine (ddI), RU-486, Medicare coverage for victims of chronic kidney failure, the human genome project, fetal tissue transplantation, and the 1975 Asilomar conference on recombinant DNA.
 

What people are saying - Write a review

We haven't found any reviews in the usual places.

Contents

Introduction
1
The Food and Drug Administration and DDI
9
Commentary
38
Commentary
41
A Political History of RU486
43
Commentary
94
Commentary
97
The Formation of Federal Policies in the United States 19861990
99
Deliberations of the Human Fetal Tissue Transplantation Research Panel
215
Commentary
249
Commentary
255
The End of the Beginning
258
Commentary
299
Commentary
302
Conclusions
308
Appendixes
323

Commentary
169
Commentary
173
The Social Security Amendments of 1972
176
Commentary
209
Commentary
212
Appendix A The Public and the Expert in Biomedical Policy Controversies
325
Appendix B Biographical Notes on Authors and Commentators
332
Index
339
Copyright

Other editions - View all

Common terms and phrases

Bibliographic information